Cargando…

Incretin-Based Therapy and Risk of Pancreatic Cancer in Patients with Type 2 Diabetes Mellitus: A Meta-analysis of Randomized Controlled Trials

INTRODUCTION: The present study aims to evaluate the risk of pancreatic cancer with incretin-based therapy among patients with type 2 diabetes mellitus (T2DM). METHODS: We searched EMBASE, MEDLINE, the Cochrane Central Register of Controlled Trials and ClinicalTrials.gov for eligible studies publish...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Han, Zhou, Xiaoying, Chen, Tao, Liu, Bingtuan, Jin, Wujuan, Gu, Huiyuan, Hong, Tianyuan, Zhang, Guoxin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2016
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5118236/ https://www.ncbi.nlm.nih.gov/pubmed/27655330 http://dx.doi.org/10.1007/s13300-016-0198-3

Ejemplares similares

Incretin treatment and risk of pancreatitis in patients with type 2 diabetes mellitus: systematic review and meta-analysis of randomised and non-randomised studies
por: Li, Ling, et al.
Publicado: (2014)

Tailored Therapy Versus Empiric Chosen Treatment for Helicobacter pylori Eradication: A Meta-Analysis
por: Chen, Han, et al.
Publicado: (2016)

Incretin and Pancreatic β-Cell Function in Patients with Type 2 Diabetes
por: Ahn, Chang Ho, et al.
Publicado: (2023)

Type 2 diabetes mellitus and the cardiometabolic syndrome: impact of incretin-based therapies
por: Schwartz, Stanley, et al.
Publicado: (2010)

Comparison of efficacy between incretin-based therapies for type 2 diabetes mellitus
por: Nisal, Kaustubh, et al.
Publicado: (2012)

Potentials of incretin‐based therapies in dementia and stroke in type 2 diabetes mellitus
por: Groeneveld, Onno N, et al.
Publicado: (2015)

Renoprotective Effects of Incretin-Based Therapy in Diabetes Mellitus
por: Yaribeygi, Habib, et al.
Publicado: (2021)

Helicobacter pylori infection related long noncoding RNA (lncRNA) AF147447 inhibits gastric cancer proliferation and invasion by targeting MUC2 and up-regulating miR-34c
por: Zhou, Xiaoying, et al.
Publicado: (2016)

Cardiovascular Effect of Incretin-Based Therapy in Patients with Type 2 Diabetes Mellitus: Systematic Review and Meta-Analysis
por: Kim, Je-Yon, et al.
Publicado: (2016)

Incretin hormones and type 2 diabetes
por: Nauck, Michael A., et al.
Publicado: (2023)

Differentiating among incretin-based therapies in the management of patients with type 2 diabetes mellitus
por: Cobble, Michael
Publicado: (2012)

Factors Related to Blood Intact Incretin Levels in Patients with Type 2 Diabetes Mellitus
por: Yoo, Soyeon, et al.
Publicado: (2019)

Incretins as a Potential Treatment Option for Gestational Diabetes Mellitus
por: Pilszyk, Aleksandra, et al.
Publicado: (2022)

Correction: Cardiovascular Effect of Incretin-Based Therapy in Patients with Type 2 Diabetes Mellitus: Systematic Review and Meta-Analysis
por: Kim, Je-Yon, et al.
Publicado: (2018)

Incretin-based therapy: a powerful and promising weapon in the treatment of type 2 diabetes mellitus
por: Koliaki, Chrysi, et al.
Publicado: (2011)

Medicinal Chemistry and Applications of Incretins and DPP-4 Inhibitors in the Treatment of Type 2 Diabetes Mellitus
por: Lotfy, Mohamed, et al.
Publicado: (2011)

Effects of incretin-based therapies on β-cell function in type 1 diabetes mellitus: a systematic review and meta-analysis
por: Wu, Yucheng, et al.
Publicado: (2021)

Incretin - based therapy in diabetes mellitus: present scenario and expanding horizons
por: Kohli, Suresh Chandra
Publicado: (2016)

Incretin-based therapies for patients with type 1 diabetes: a meta-analysis
por: Liu, Lili, et al.
Publicado: (2019)

Pancreatitis Associated With Incretin-Based Therapies
por: Iyer, Shridhar N., et al.
Publicado: (2013)

The Incretins and Pancreatic β-Cells: Use of Glucagon-Like Peptide-1 and Glucose-Dependent Insulinotropic Polypeptide to Cure Type 2 Diabetes Mellitus
por: Kim, Mi-Hyun, et al.
Publicado: (2010)

Comparison of incretin immunoassays with or without plasma extraction: Incretin secretion in Japanese patients with type 2 diabetes
por: Yabe, Daisuke, et al.
Publicado: (2011)

Incretin based drugs and risk of acute pancreatitis in patients with type 2 diabetes: cohort study
por: Faillie, Jean-Luc, et al.
Publicado: (2014)

Linagliptin Increases Incretin Levels, Lowers Glucagon, and Improves Glycemic Control in Type 2 Diabetes Mellitus
por: Rauch, Thomas, et al.
Publicado: (2012)

The catcher in the gut: Tirzepatide, a dual incretin analog for the treatment of type 2 diabetes mellitus and obesity
por: Lempesis, Ioannis G., et al.
Publicado: (2022)

Anti-atherosclerotic effect of incretin mimetics: a meta-analysis of randomized controlled trials
por: Barbarawi, Mahmoud, et al.
Publicado: (2018)

Incretins and cardiovascular disease: to the heart of type 2 diabetes?
por: Solini, Anna, et al.
Publicado: (2023)

Insulin Secretion and Incretin Hormone Concentration in Women with Previous Gestational Diabetes Mellitus
por: Yu, Sung Hoon, et al.
Publicado: (2011)

12-month effects of incretins versus SGLT2-Inhibitors on cognitive performance and metabolic profile. A randomized clinical trial in the elderly with Type-2 diabetes mellitus
por: Perna, Simone, et al.
Publicado: (2018)

Effect of Long-term Incretin-Based Therapies on Ischemic Heart Diseases in Patients with Type 2 Diabetes Mellitus: A Network Meta-analysis
por: Chou, Che-Yi, et al.
Publicado: (2017)

Cognitive protection of incretin‐based therapies in patients with type 2 diabetes mellitus: A systematic review and meta‐analysis based on clinical studies
por: Chai, Sanbao, et al.
Publicado: (2023)

Cardiovascular Safety of Incretin-Based Therapies in Type 2 Diabetes: Systematic Review of Integrated Analyses and Randomized Controlled Trials
por: Mannucci, Edoardo, et al.
Publicado: (2016)

Incretin based treatments and mortality in patients with type 2 diabetes: systematic review and meta-analysis
por: Liu, Jiali, et al.
Publicado: (2017)

The evolving place of incretin-based therapies in type 2 diabetes
por: Gallwitz, Baptist
Publicado: (2010)

Incretin response in Asian type 2 diabetes: Are Indians different?
por: Singh, Awadhesh Kumar
Publicado: (2015)

Updates of incretin‐related drugs for the treatment of type 2 diabetes
por: Araki, Hirotaka, et al.
Publicado: (2022)

What Are Incretins, and How Will They Influence the Management of Type 2 Diabetes?
por: Bonde, Lawrence, et al.
Publicado: (2006)

Beyond Glycemic Control in Diabetes Mellitus: Effects of Incretin-Based Therapies on Bone Metabolism
por: Ceccarelli, Elena, et al.
Publicado: (2013)

A novel technique for removing large gastric subepithelial tumors with ESD method in the subcardia region
por: Liu, Bingtuan, et al.
Publicado: (2019)

Opportunities and challenges of incretin-based hypoglycemic agents treating type 2 diabetes mellitus from the perspective of physiological disposition
por: Xie, Yaochen, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_opscnfd8pdbemde4esduub8qd8